Marialessandra Contino

27PUBLICATIONS
93CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesProteins and peptidesBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 08, 2026
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.

|Jun 18, 2026
Dual-Acting Vitamin B<sub>3</sub>-Melanostatin Neuropeptide Hybrids as Potent Modulators of the Dopamine D<sub>2</sub> Receptors with Neuroprotective Activity.

|May 27, 2026
Correction: Kopecka et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. <i>Cells</i> 2020, <i>9</i>, 1033.

|Dec 17, 2025
Zervimesine, a Small Sigma‑2 Receptor Selective Modulator for Alzheimer's Disease.

Isabel Iriepa, Marialessandra Contino, Carmen Abate

|Aug 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB<sub>2</sub> Agonists with Neuroprotective Effects.

Claudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz

|Feb 20, 2025
Identification of a Cannabinoid Receptor 2 Allosteric Site Using Computational Modeling and Pharmacological Analysis.

Zara Farooq, Pietro Delre, Stylianos Iliadis

Pageof 5

Frequent Collaborators

13 joint publications

Chiara Riganti

7 joint publications

Giuseppe Felice Mangiatordi

7 joint publications

Maria Grazia Perrone

7 joint publications

Angela Stefanachi